Riskpilot← Back to searchSign inGet full accessVitaform AB
ABActiveOrg 5565350047Alekärrsvägen 30Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19960 employees
Revenue 2024
SEK 655K
+67% vs 2023
EBITDA margin
18.0%
+320% vs 2023
Equity ratio
61.7%
Financial strength
Net profit 2024
SEK 108K
+264% vs 2023
| Revenue | SEK 655K | +67% |
| EBITDA | SEK 118K | +320% |
| Net profit | SEK 108K | +264% |
| Total assets | SEK 422K | +48% |
| Equity | SEK 261K | +71% |
| Employees | 0 | — |
Legal name
Vitaform AB
Org number
5565350047
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
21 oktober 1996
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva handel med medicinsk och komplementär- medicinsk utrustning, hudvårdsprodukter, kosttillskott och livsmedel samt utföra komplemntärmedicinska behandlingar. Bolaget skall även bedriva därtill angränsande verksamheter.
Address
Alekärrsvägen 30
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 819 | 976 | 519 | 392 | 655 |
| Staff expenses | — | — | −448 | −255 | −136 |
| EBITDA | 94 | 115 | −100 | −54 | 118 |
| Depreciation & amort. | −10 | −10 | −10 | −10 | −10 |
| EBIT | 84 | 105 | −111 | −64 | 108 |
| Net financials | 2 | −2 | 0 | −2 | 0 |
| Profit before tax | 85 | 102 | −111 | −66 | 108 |
| Tax | −0 | −7 | — | — | — |
| Net profit | 85 | 95 | −111 | −66 | 108 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 452 | 550 | 313 | 285 | 422 |
| Equity | 234 | 329 | 219 | 153 | 261 |
| Long-term debt | 126 | 113 | 46 | 47 | 50 |
| Short-term debt | 92 | 108 | 48 | 84 | 112 |
| Total debt | 218 | 221 | 94 | 132 | 162 |
EBITDA margin
18.0%
This company
15.8%
Market median
+14% vs market
20202024
Equity ratio
61.7%
This company
38.2%
Market median
+62% vs market
20202024
Return on equity
41.4%
This company
18.4%
Market median
+125% vs market
20202024
Net profit margin
16.5%
This company
8.1%
Market median
+104% vs market
20202024
Asset turnover
1.55×
This company
1.12×
Market median
+38% vs market
20202024
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vitaform AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dag Kristian Johnson | Board of Directors | 0 companies |
| Carina Elisabeth Johnson | Deputy Board Member | 0 companies |